Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Zeo ScientifiX ( (ZEOX) ) has issued an update.
On March 31, 2026, ZEO ScientifiX announced it had been named the official educational partner for regenerative medicine with the American Academy of Anti-Aging Medicine at Longevity SpringFest 2026, reflecting its deep focus on regenerative biologics and clinical translation. The company will lead a full-day Regenerative & Longevity Medicine Masterclass on April 9, 2026, in West Palm Beach, Florida, modeled on A4M’s Professional Medical Education series and aimed at advanced practitioners.
Through this role, ZEO gains direct access to A4M’s global network of 26,000 physicians and healthcare practitioners across more than 120 countries, bolstering its profile in the $29.9 billion longevity therapy market. The partnership places ZEO alongside other industry-leading public companies within A4M’s educational network, and the masterclass will cover scientific foundations of biologics, real-world clinical integration, and navigation of federal and Florida-specific regulatory requirements.
More about Zeo ScientifiX
ZEO ScientifiX, Inc. is an SEC-reporting, clinical-stage biopharmaceutical company focused on researching, developing, and manufacturing regenerative biologics for clinical use. Operating from Nova Southeastern University’s $100 million Center of Collaborative Research, the company aims to translate emerging regenerative science into scalable therapeutic solutions for the growing longevity and regenerative medicine markets.
The company’s work positions it squarely within the broader longevity therapy sector, which is estimated at $29.9 billion, and aligns it with other public players focused on advanced biologics and anti-aging interventions. By emphasizing evidence-based approaches and regulatory compliance, ZEO targets physicians and healthcare practitioners seeking rigorous, clinically applicable regenerative medicine tools and education.
Average Trading Volume: 5,761
Technical Sentiment Signal: Buy
Current Market Cap: $16.41M
For an in-depth examination of ZEOX stock, go to TipRanks’ Overview page.